Missing Avatar

Joshua Brody

View Biosketch →

  • Joshua Brody hasn't added any employment information yet...

  • Joshua Brody hasn't added any educational information yet...

Publication Info
Orthostatic hypotension and novel blood pressure-associated gene variants: Genetics of Postural Hemodynamics (GPH) Consortium. Fedorowski A, Franceschini N, Brody J, Liu C, Verwoert GC, Boerwinkle E, Couper D and 16 others Eur Heart J. :. doi: 10.1093/eurheartj/ehs058. April 14, 2012. View on PubMed.
Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals. Dastani Z, Hivert MF, Timpson N, Perry JR, Yuan X, Scott RA, Henneman P and 563 others PLoS Genet. 8(3):e1002607. doi: 10.1371/journal.pgen.1002607. 2012. View on PubMed.
Acute basophilic leukemia associated with loss of gene ETV6 and protean complications. Kritharis A, Brody J, Koduru P, Teichberg S, Allen SL J Clin Oncol. 29(21):e623-6. doi: 10.1200/JCO.2010.34.5710. July 20, 2011. View on PubMed.
Active and passive immunotherapy for lymphoma: proving principles and improving results. Brody J, Kohrt H, Marabelle A, Levy R J Clin Oncol. 29(14):1864-75. doi: 10.1200/JCO.2010.33.4623. May 10, 2011. View on PubMed.
CD137 stimulation enhances the antilymphoma activity of anti-CD20 antibodies. Kohrt HE, Houot R, Goldstein MJ, Weiskopf K, Alizadeh AA, Brody J, Müller A and 7 others Blood. 117(8):2423-32. doi: 10.1182/blood-2010-08-301945. February 24, 2011. View on PubMed.
A CpG-loaded tumor cell vaccine induces antitumor CD4+ T cells that are effective in adoptive therapy for large and established tumors. Goldstein MJ, Varghese B, Brody JD, Rajapaksa R, Kohrt H, Czerwinski DK, Levy S, Levy R Blood. 117(1):118-27. doi: 10.1182/blood-2010-06-288456. January 6, 2011. View on PubMed.
Transitioning a cancer patient from high-dose intravenous hydromorphone therapy to intravenous methadone. LeBaron V, Brody J, Lee EM, Hardin C, Snyder L J Pain Palliat Care Pharmacother. 25(4):356-61. doi: 10.3109/15360288.2011.620688. 2011. View on PubMed.
In situ vaccination with a TLR9 agonist induces systemic lymphoma regression: a phase I/II study. Brody JD, Ai WZ, Czerwinski DK, Torchia JA, Levy M, Advani RH, Kim YH and 6 others J Clin Oncol. 28(28):4324-32. doi: 10.1200/JCO.2010.28.9793. October 1, 2010. View on PubMed.
Airway PI3K pathway activation is an early and reversible event in lung cancer development. Gustafson AM, Soldi R, Anderlind C, Scholand MB, Qian J, Zhang X, Cooper K and 10 others Sci Transl Med. 2(26):26ra25. doi: 10.1126/scitranslmed.3000251. April 7, 2010. View on PubMed.
Improved characterization of focal liver lesions with liver-specific gadoxetic acid disodium-enhanced magnetic resonance imaging: a multicenter phase 3 clinical trial. Raman SS, Leary C, Bluemke DA, Amendola M, Sahani D, McTavish JD, Brody J and 11 others J Comput Assist Tomogr. 34(2):163-72. doi: 10.1097/RCT.0b013e3181c89d87. April 2010. View on PubMed.
A dual-targeting PDGFRbeta/VEGF-A molecule assembled from stable antibody fragments demonstrates anti-angiogenic activity in vitro and in vivo. Mabry R, Gilbertson DG, Frank A, Vu T, Ardourel D, Ostrander C, Stevens B and 21 others MAbs. 2(1):20-34. February 2010. View on PubMed.
Lymphoma immunotherapy: vaccines, adoptive cell transfer and immunotransplant. Brody J, Levy R Immunotherapy. 1(5):809-24. doi: 10.2217/imt.09.50. September 2009. View on PubMed.
Immunotransplantation preferentially expands T-effector cells over T-regulatory cells and cures large lymphoma tumors. Brody JD, Goldstein MJ, Czerwinski DK, Levy R Blood. 113(1):85-94. doi: 10.1182/blood-2008-05-155457. January 1, 2009. View on PubMed.
Treatment of mantle cell lymphoma: current approach and future directions. Brody J, Advani R Crit Rev Oncol Hematol. 58(3):257-65. doi: 10.1016/j.critrevonc.2005.10.001. June 2006. View on PubMed.
Using signaling pathways to overcome immune tolerance to tumors. Engleman EG, Brody J, Soares L Sci STKE. 2004(241):pe28. doi: 10.1126/stke.2412004pe28. July 6, 2004. View on PubMed.
DC-based cancer vaccines: lessons from clinical trials. Brody JD, Engleman EG Cytotherapy. 6(2):122-7. doi: 10.1080/14653240410005267. 2004. View on PubMed.
CD28 receptor endocytosis is targeted by mutations that disrupt phosphatidylinositol 3-kinase binding and costimulation. Céfaï D, Schneider H, Matangkasombut O, Kang H, Brody J, Rudd CE J Immunol. 160(5):2223-30. March 1, 1998. View on PubMed.
  • Joshua Brody hasn't received any ratings yet...